Assetmark, Inc Lantheus Holdings, Inc. Transaction History

Assetmark, Inc

$47.4 Billion
Q4 2025

A detailed history of Assetmark, Inc transactions in Lantheus Holdings, Inc. stock. As of the latest transaction made, Assetmark, Inc holds 118,300 shares of LNTH stock, worth $6.27 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

118,300

Previous 118,503 0.17%

Holding current value

$6.27 Million

Previous $6.08 Million 3.18%

% of portfolio

0.01%

Previous 0.01%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2025 Jan 23, 2026	SELL	$50.69 - $58.13 $10,290 - $11,800	-203 Reduced 0.17%	118,300 $6.27 Million
Q3 2025 Nov 06, 2025	BUY	$50.11 - $83.83 $994,382 - $1.66 Million	19,844 Added 20.11%	118,503 $6.08 Million
Q2 2025 Aug 04, 2025	SELL	$73.86 - $108.74 $204,739 - $301,427	-2,772 Reduced 2.73%	98,659 $8.08 Million
Q1 2025 May 06, 2025	BUY	$78.23 - $110.01 $2.53 Million - $3.56 Million	32,372 Added 46.88%	101,431 $9.9 Million
Q4 2024 Feb 06, 2025	BUY	$76.22 - $116.71 $476,908 - $730,254	6,257 Added 9.96%	69,059 $6.18 Million

Q3 2024 Nov 01, 2024	BUY	$77.7 - $123.62 $500,543 - $796,360	6,442 Added 11.43%	62,802 $6.89 Million
Q2 2024 Aug 13, 2024	BUY	$58.87 - $83.05 $3.32 Million - $4.68 Million	56,360 New	56,360 $4.53 Million
Q4 2023 Feb 09, 2024	BUY	$55.6 - $77.89 $152,288 - $213,340	2,739 Added 42.9%	9,123 $565,000
Q3 2023 Oct 27, 2023	BUY	$60.27 - $90.75 $384,763 - $579,348	6,384 New	6,384 $443,000
Q1 2023 May 05, 2023	SELL	$47.76 - $82.86 $3,152 - $5,468	-66 Reduced 82.5%	14 $1,000
Q3 2022 Nov 01, 2022	BUY	$61.42 - $86.29 $4,913 - $6,903	80 New	80 $6,000
Q1 2018 May 16, 2018	SELL	$14.85 - $24.3 $148 - $243	-10 Closed	0 $0
Q4 2017 Feb 13, 2018	BUY	$17.4 - $23.4 $174 - $234	10	10 $0

Others Institutions Holding LNTH

# of Institutions

476

Shares Held

72.8M

Call Options Held

522K

Put Options Held

312K

View Full List

About Lantheus Holdings, Inc.

Ticker LNTH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 68,741,904
Market Cap $3.64B
Description
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...

More about LNTH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Assetmark, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Assetmark, Inc with notifications on news.

Account